2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-2023339835-A1 · Oct 26, 2023 · US
This page is not indexed by search engines while we improve data quality.
Hinman Andrew W patents
Hinman Andrew W is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hinman Andrew W |
| Total patents | 17 |
| First publication | Jan 7, 2016 |
| Latest publication | Oct 26, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-11746077-B2 · Sep 5, 2023 · US
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US-11680034-B2 · Jun 20, 2023 · US
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-11667596-B2 · Jun 6, 2023 · US
Methods and compositions for treatment of inflammation and oxidative stress
US-2022257533-A1 · Aug 18, 2022 · US
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-2022220054-A1 · Jul 14, 2022 · US
Process for the production of alpha-tocotrienol and derivatives
US-2022204469-A1 · Jun 30, 2022 · US
Process for the production of alpha-tocotrienol and derivatives
US-11312697-B2 · Apr 26, 2022 · US
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-2022106248-A1 · Apr 7, 2022 · US
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-11174212-B2 · Nov 16, 2021 · US
Recent patents
Latest publications not already listed above.
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
US-2021276937-A1 · Sep 9, 2021 · US
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US-2021238119-A1 · Aug 5, 2021 · US
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US-10981855-B2 · Apr 20, 2021 · US
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US-2020331835-A1 · Oct 22, 2020 · US
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US-10703701-B2 · Jul 7, 2020 · US
Resorcinol compounds for dermatological use
US-10470986-B2 · Nov 12, 2019 · US
Resorcinol compounds for dermatological use
US-2016000669-A1 · Jan 7, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ptc Therapeutics Inc | 15 |
| Conopco Inc | 1 |
| Conopco Inc Dba Unilever | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/00 | 12 |
| A61P25/28 | 12 |
| C07C39/08 | 9 |
| A61K31/122 | 8 |
| A61P21/00 | 7 |